It will, therefore, be valuable to investigate the clinical benefits of thiamine therapy in the management of hepatic steatosis and of combination therapies using both thiamine and insulin sensitizers for management of FL disorders that involve insulin resistance, such as MAFLD. Here, INS is linked to fatty liver disease.